Immunome (IMNM) Shares Issued: 2023-2025
Historic Shares Issued for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $45.5 million.
- Immunome's Shares Issued was N/A to $45.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.2 million, marking a year-over-year change of. This contributed to the annual value of $20.0 million for FY2024, which is 84.00% down from last year.
- As of Q3 2025, Immunome's Shares Issued stood at $45.5 million, which was up 21,048.37% from $215,000 recorded in Q2 2025.
- In the past 5 years, Immunome's Shares Issued registered a high of $125.0 million during Q2 2023, and its lowest value of $34,000 during Q1 2023.
- Over the past 3 years, Immunome's median Shares Issued value was $9.8 million (recorded in 2024), while the average stood at $31.6 million.
- The largest annual percentage gain for Immunome's Shares Issued in the last 5 years was 9,979.41% (2024), contrasted with its biggest fall of 99.76% (2024).
- Immunome's Shares Issued (Quarterly) stood at $64.0 million in 2023, then plummeted by 74.58% to $16.3 million in 2024, then dropped by 28.33% to $45.5 million in 2025.
- Its Shares Issued stands at $45.5 million for Q3 2025, versus $215,000 for Q2 2025 and $213,000 for Q1 2025.